Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)
Titel:
Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)
Auteur:
Chen, Sean T. Hellkamp, Anne S. Becker, Richard C. Berkowitz, Scott D. Breithardt, Günter Fox, Keith A.A. Hacke, Werner Halperin, Jonathan L. Hankey, Graeme J. Mahaffey, Kenneth W. Nessel, Christopher C. Piccini, Jonathan P. Singer, Daniel E. Patel, Manesh R.